The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Update on Legislation, Advocacy Efforts to Advance Rheumatology

Update on Legislation, Advocacy Efforts to Advance Rheumatology

September 1, 2014 • By Joseph Flood, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

The partisan end to this chapter of the SGR saga did not reflect the bipartisan, bicameral nature of the agreement itself. This agreement was years in the making. The ACR was asked several times to help with the language of the agreement, and several of our recommendations were incorporated. The opportunity for us to have a voice in the crafting of this legislation was a landmark in our endeavors to represent the needs of our members and their patients. Although not perfect, the bill is our best chance for repealing the SGR and replacing it with a formula recognizing the care we provide for patients. If passed, the agreement will afford us more of a say in quality metrics that will be incorporated in new payment models based on quality. We have heard from congressional leaders that the SGR will almost certainly not be taken up in the lame duck session, so we hope to help get this done in early 2015.

You Might Also Like
  • ACR Aims to Keep Rheumatology on Congressional Radar in 2014
  • Congress Can Begin Work to Advance Rheumatology Before New Year
  • Rheumatology Advocacy Starts at Home
Explore This Issue
September 2014
Also By This Author
  • The ACR President Joseph Flood, MD, Reviews Past Year in Rheumatology

The ACR has played an active role to promote more clinically meaningful measures of quality care for rheumatologists, along with the development of tools to make it easy for rheumatologists to measure and report on quality measures for federal programs. The ACR’s RISE registry launched earlier this year, and it’s now certified by CMS as a qualified clinical data registry for quality reporting and meets the Meaningful Use requirement of reporting to a specialty registry. Easy reporting of performance on quality measures will help rheumatologists avoid payment penalties from the reporting programs and gives rheumatologists a better chance for payment increases in whichever new payment system is eventually implemented.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Because Congress could not agree on how to pay for the repeal of SGR, they passed yet another SGR patch. The patch ends March 31, 2015, when 20%-plus cuts to Medicare reimbursement will happen unless Congress acts (again). Congress included provisions in the latest patch that constitute a major win for rheumatology and marks us as successful in our efforts to really make change for you.

The patch included a one-year delay of ICD-10 implementation, until Oct. 1, 2015. The ACR was on Capitol Hill and at RheumPAC fundraisers discussing problems with ICD-10 when the opportunity to include the ICD-10 delay in the latest patch presented itself. Our advocacy activities put us at the center of the process, and the ACR’s work at that key time played a major role in making the ICD-10 delay a reality. This was something you told us was necessary, and we were able to help get it done for you and the rest of the House of Medicine. Your RheumPAC contributions are partly responsible for putting us in this position. Your e-mails and calls to Congress also played a crucial role in enhancing the ACR presence in critical meetings at auspicious times.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 4 5 | Single Page

Filed Under: Billing/Coding, Biologics & Biosimilars, Drug Updates, Legislation & Advocacy, Practice Management, President's Perspective, Professional Topics, Quality Assurance/Improvement Tagged With: AC&R, Advocacy, American College of Rheumatology, ARHP, Association of Rheumatology Health Professionals, Billing, Biologics, Biosimilars, Coding, drug, ICD-10, Legislation, Medicare, Practice Management, Research, rheumatologist, SGR, TechnologyIssue: September 2014

You Might Also Like:
  • ACR Aims to Keep Rheumatology on Congressional Radar in 2014
  • Congress Can Begin Work to Advance Rheumatology Before New Year
  • Rheumatology Advocacy Starts at Home
  • Much at Stake for Rheumatology in Lame Duck Session of Congress

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.